Skip to content
healthcare.dev
Get a free key

Cholestyramine

NDC 51224-011, Cholestyramine, powder, for suspension, from TAGI Pharma, Inc..

Product NDC
51224-011
Status
Listed
Labeler
TAGI Pharma, Inc.
Dosage form
POWDER, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209597
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51224-011 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CHOLESTYRAMINE4 g/8.3g

Pharmacologic classes

Bile Acid Sequestrant [EPC]; Bile-acid Binding Activity [MoA]

Package NDCNDC-11Package
51224-011-1051224001110348.6 g in 1 CAN (51224-011-10)
51224-011-205122400112060 POUCH in 1 CARTON (51224-011-20) / 8.3 g in 1 POUCH

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/06261db5-1435-4b91-8b54-71bfcfb1368c

Use it

Look up 51224-011 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51224-011 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51224-011. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.